We describe the cloning of the mouse glial cell line-derived neurotrophic factor (GDNF) gene and its expression during embryogenesis. GDNF is a distant member of the superfamily of TGF-/3 related genes that was originally identified on the basis of its striking neurotrophic activity. GDNF is expressed in a highly dynamic pattern in the anterior neuroectoderm during early stages of neurogenesis between E7.5 and E10.5. Beginning at E10.5 GDNF is also expressed in several organs that develop through inductive epithelialmesenchymal interactions. In those organs, GDNF expression is strictly confined to mesenchymal tissues and is not found in epithelia. Our results suggest multiple roles for GDNF during early stages of neuronal development and in epithelial-mesenchymal interactions.
Introduction
Recent studies of the effects of neurotrophic factors in vitro and in vivo have firmly established their efficacy in promoting the survival, function and differentiation of many classes of neurons. Of the neurotrophic factors that have been studied, one of the most effective is glial cell line-derived neurotrophic factor (GDNF). GDNF was first isolated and cloned on the basis of its ability to promote high-affinity dopamine uptake, survival and morphological differentiation of embryonic midbrain dopaminergic neurons in culture (Lin et al., 1993) . The effect of GDNF on mesencephalic dopaminergic cells seemed quite specific; it had no effect on GABA or 5HT neurons.
Two recent reports further substantiate the possible role of GDNF in promoting the survival and/or development of dopamine neurons in vivo and in culture (Beck et al., 1995; Tomac et al., 1995) . Intracerebral injections of GDNF over the substantia nigra or in the striatum before administration of the dopaminergic neurotoxin l-methyl- 4-phenyl-1,2,3,6_tetrahydropyridine (MPTP), which produces parkinsonian-like symptoms in humans, substantially protected the nigrostriatal system from the toxic effects of MPTP (Tomac et al., 1995) . The second study showed that injection of GDNF adjacent to the substantia nigra largely prevented the axotomy-induced degeneration of mesencephalic dopaminergic neurons in the adult brain (Beck et al., 1995) .
Unlike other factors promoting dopamine uptake and/ or survival of dopaminergic neurons in embryonic midbrain cultures, such as insulin-like growth factors (IGFs), epidermal growth factor (EGF), and fibroblast growth factors (FGFs), GDNF was not mitogenic. These observations suggested that GDNF might have utility as a therapeutic agent for neurodegenerative disorders such as Parkinson's disease which is characterized by the degeneration of midbrain dopaminergic neurons.
GDNF has also been found to be a potent survival factor for motor neurons in peripheral nerves and muscle (Henderson et al., 1994; Oppenheim et al., 1995; Yan et al., 1995) . Its efficacy is comparable to or exceeds that of brain-derived neurotrophic factor (BDNF) and neurotrophin 4/5. Oppenheim et al. (1995) demonstrated that not only did GDNF enhance the survival of chick embryo motor neurons in culture, but it also rescued developing avian motor neurons from naturally programmed cell death in vivo. Yan et al. (1995) found that GDNF is retrogradely transported, in a receptor-mediated fashion, by spinal cord motor neurons in neonatal rats. They also reported that application of GDNF to the transected facial nerve prevents the massive motor neuron cell death and atrophy that normally follows axotomy in the neonatal period. Therefore, GDNF might also be useful for therapeutic treatment of motor neuron disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophies (SMA).
GDNF is a distantly related member of the transforming growth factor-beta (TGF-B) superfamily (Lin et al., 1993; Kingsley, 1994) . It shares the seven conserved cysteine residues with the same relative spacing found in all members of the TGF-/I family, but shows less than 25% amino acid identity with the other family members. Like most of the other family members, GDNF is synthesized as a precursor molecule with an amino-terminal signal sequence and a pro-domain which is proteolytically cleaved to release a mature protein of 134 amino acids (Lin et al., 1993) . Despite the low sequence homology with the other members of the TGF-p family, physiologically, GDNF may share some of the same functions as various members of this family. As a group, the members of the TGF-@ family display a broad and diverse range of effects on normal growth and during development (Sporn and Roberts, 1992; Roberts and Sporn, 1993; Kingsley, 1994) . TGF-B family members have neurotrophic effects as well. Like GDNF, TGF-/3s l-3 and activin A promote the survival of developing dopaminergic neurons cultured from rat embryonic midbrain (Kreiglstein et al., 1995) .
To get an insight into the role GDNF might play during development, we cloned the mouse GDNF locus and analyzed the expression pattern of the GDNF gene in developing mouse embryos by in situ hybridization. We describe here the structure of the murine GDNF locus and show that GDNF is expressed early during embryonic development in anterior neuroectoderm. At later stages of development, expression is primarily detected in tissues of mesenchymal origin, suggesting a potential role as a signaling molecule in these tissues during development.
Results

Cloning and structure of the murine GDNF locus
Screening of one million recombinant phages of a mouse 129/SV genomic lambda phage library with the GDNF cDNA clone yielded 30 positive clones of which 21 were rescreened and four were eventually plaque purified. Two overlapping phage clones, 14a and 21, were found to contain the first coding exon and the second coding exon, respectively (Fig. 1A) . The mouse and the human (Lin et al., 1993) genes have similar exon-intron organizations. The first coding exon is separated from the second coding exon by an intron of at least 10 kb. Sequencing of the mouse exons indicated that the GDNF gene is highly conserved across species. The mouse gene has 97% identity with the rat and 89% identity with the human GDNF genes at the nucleotide level and 99% and 93% identity at the amino acid level with the rat and human genes, respectively (Fig. 1B) . 
Expression of GDNF during early embryonic development
The expression pattern of GDNF during early embryogenesis was studied by whole mount in situ hybridization in E7.5-El05 embryos and in sections of embryos ElOS-E15.5.
In whole mounts, GDNF mRNA expression is detected at E7.5 (the earliest stage analyzed), reaches its peak around E9.5 and declines considerably after E10.5. At E7.5, GDNF is localized in the anterior portion of the neuroectoderm corresponding to the developing forebrain (data not shown). At E8.5, labeling was found in the neuroectoderm surrounding the optic vesicle ( Fig.   2A ). Twelve hours later, the domain of expression is still restricted to the anterior neuroectoderm, but it is more widespread in the neuroepithelial wall of the prospective forebrain and midbrain (Fig. 2B,C) . At E9.5, the domain of GDNF expression extends along the whole anteriorposterior axis of the embryo. At the anterior end, GDNF is found in the neuroepithelial wall of all brain regions, surrounding both optic and otic vesicles, and in the first and second brachial arches (Fig. 2D,E) . It is detected all along the dorsal spinal cord and at the posterior end of the embryo in the tail bud and lateral plate mesoderm. Sections through the tail demonstrate that in the more posterior regions, GDNF mRNA is present in the ventricular zone and dorsal portion of the neural tube, dorsolateral portion of the somites in the prospective dermomyotome and lateral body wall (data not shown). In more anterior sections, only the dorsal neural tube labeling remains. At this stage, GDNF is also expressed very strongly throughout the mesenchymal tissues of the limb buds. The same structures and tissues express GDNF mRNA at El05 (Fig. 2F ).
GDNF expression during organogenesis
In older embryos from E10.5-E15.5, GDNF expression is detected primarily in mesenchyme or tissues derived from mesenchyme.
GDNF transcripts are found in the developing digestive tract, kidney, testes, frontonasal mass, tooth primordium, tongue, mandible and in the primordia of whisker follicles. GDNE expression is found in the paravertebral (intercostal) mesenchyme and in the cartilage primordium of the ear, in the mesenchymal components of the developing eye, and in the limbbud and interdigital mesenchyme.
Expression of GDNF is not detected in the developing brain after E10.5, except for two discrete regions in the neuroepithelial wall of the fourth ventricle in the hindbrain. Strong GDNF expression is seen in these regions as early as E10.5, and interestingly, can be seen as a sharp, clearly demarcated band in this region at each subsequent day of development (Fig. 3) .
GDNF expression in developing gastrointestinal tract
One of the most prominent aspects of the developmental expression pattern of GDNF was a strong signal over the mesenchymal layer of the gastrointestinal tract. This signal was present at all levels from the esophagus to the rectum at all developmental stages. Between E9.0 and E10.5, when the simple tube-like gut is elongating and differentiating into regions such as the rapidly expanding stomach primordium, high levels of GDNF mRNA are seen in the stomach, the duodenum and the cloaca (Fig.  4) . From El 1.5 to E15.5, GDNF is expressed at high levels throughout the length of the developing gastrointesti- expression at E13.5. We found strong labeling in mesenchymal tissues of the digestive tract at all embryonic stages and at all levels: (CD) in the esophagus, which is outlined by arrows; (E,fl the stomach (s indicates the lumen of the stomach); (G,H) in the intestine and rectum, outlined by arrowheads. nal tract, from the esophagus to the rectum which develops from the cloaca1 cavity as well as in the umbilical hernia, an extension of the midgut into the umbilical cord, both of which are formed by El 1.0 (Fig. 4) . During the period of differentiation of the gut, it is covered in varying levels of thickness by splanchnic mesoderm composed mostly of loose mesenchymal cells which will contribute to the formation of the connective tissue and smooth muscle of the various regions of the gut. We find the hybridization signal ,primarily over the outer mesenchymal layer of the gut and subsequently in later stages in the outer smooth muscle layer.
GDNF expression in developing kidney and testis
The mature mammalian kidney, the metanephros, begins differentiating by E12.0-E12.5 in the mouse embryo. GDNF mRNA expression is seen as early as E 11.5 in the presumptive metanephros (data not shown). At E13.5, we detect GDNF transcripts in the undifferentiated cortical mesenchymal tissue adjacent to the condensing mesenthyme surrounding the uretric buds (Fig. 5A,B) . The pattern of GDNF expression in the undifferentiated cortical mesenchyme is maintained through E15.5 (Fig. 5E,F) .
GDNF transcripts are also detected in the developing testis at E15.5 (Fig. 5G,H) . Only two types of cells are identifiable in the testis cords by day 15.5 of mouse development, the type A spermatogonia and indifferent cells, some of which differentiate into Sertoli cells. GDNF mRNA expression is confined to the precursors of Sertoli cells (Fig. 5G,H) and is not found in the interstitium.
Expression of GDNF in mesenchyme surrounding developing limbs, digits, and ribs
At E10.5, just after the hindlimb buds first make their appearance in the developing embryo, expression of The dental laminae or the tooth primordia are first seen GDNF is seen in the limb buds (Figs. 2F and 6A,B) . around E13.0 and the tooth buds of the first molars make Strong expression of GDNF is also detected in the mesentheir appearance in the mouse embryo by E14.0. GDNF is chymal connective tissue surrounding the cartilaginous expressed in the tooth bud mesenchyme at E14.5 and in components of the developing digits which are entirely the mesenchymal tissue underlying the tongue and manseparated in El55 embryos (Fig. 6C,D) . GDNF is also dibular epithelium. We also see strong expression of expressed in other mesenchymal tissues surrounding carti-GDNF in the connective tissue mesenchyme surrounding lage primordia such as in the pericartilage mesenchyme of the vibrissae papillae which are actively developing in the femur (Fig. 6E,F ) and the costae (Fig. 6G,H) .
E14.5 and E15.5 embryos (Fig. 7) .
2.7. GDNF expression in the head and pharyngeal arches 3. Discussion GDNF is widely expressed in several regions of the developing head. At E10.5, a strong hybridization signal for GDNF is seen in the first pharyngeal arch, part of which develops into the tubo-tympanic recess by El 1.5. Much of the developing ear is of mesenchymal origin including the cartilaginous components and the tympanic cavity and auditory tube which are derived from the first pharyngeal pouch. By E14.5, GDNF expression is detected in the mesenchymal components of both the developing ear, nose, and eye (Fig. 7) .
In the present study, we have cloned the mouse GDNF gene, examined its structure and assessed its expression pattern during embryonic development. The highly conserved nature of this gene and its restricted expression pattern suggest an important developmental function for GDNF.
GDNF expression within the neuroectoderm of postimplantation E7.5 to E9.5 embryos suggests that it plays a part in regulating early stages of neuronal differentiation. Expression in the developing nervous system is dynamic Fig. 6 . Expression in limb buds (A,B) and pericartilage mesenchyme (C-H). GDNF is expressed in El03 embryos in the posterior region of the limb buds, in the zone of polarizing activity. At E15.5 it is expressed in the pericartilage digital mesenchyme (CD), and also in the pericartilage mesenthyme of the femur (E,F), and the intercostal mesenchyme (G,H). a, anterior; p, posterior; d, digital cartilage; cp, cartilage primordium; c, costal cartilage; I, intercostal mesenchyme. and shows regionalization along both the anterio-posterior and dorso-ventral axes. Initially, strongest expression is in the developing forebrain region. Ultimately GDNF is expressed along the entire anterio-posterior axis in the CNS with transcripts being enriched in the dorsal part of the neural tube.
After E10.5, GDNF expression in the CNS is restricted to two discrete domains in ventro-lateral regions of the rostra1 and caudal hindbrain. Expression in these domains remains remarkably constant until E15.5, the last stage examined, and also appears to be present in neonatal rats (see Fig. 3 in Poulsen et al., 1994) . The unambiguous correlation with discrete neuronal structures awaits further analysis of older embryonic stages. Interestingly, we did not find GDNF expression in the ventral midbrain, where dopaminergic cell bodies reside, or in dopaminergic target areas such as the ganglionic eminence (striaturn), cortex, or olfactory bulb at any of the developmental stages we examined, indicating that GDNF is not an important factor for early differentiation of dopaminergic neurons. However, it is known that maturation of dopaminergic innervation of target tissues occurs in the late prenatal and early postnatal periods (Voorn et al., 1988; Lindsay et al., 1994) . Studies of GDNF expression in the rat have shown that it is expressed at later developmental stages in striatal and ventral limbic dopaminergic target --.-. areas (Stromberg et al., 1993; Poulsen et al., 1994) . GDNF has also been detected by PCR in adult human striatum, hippocampus, cortex, and spinal cord (Springer et al., 1994) .
Non-neuronal GDNF expression is found in tissues that rely on inductive interactions between epithelia and mesenchyme for their development. Reciprocal and sequential epithelial-mesenchymal interactions play a vital role in the development of many organs, including the limbs (Tickle and Eichele, 1994) , gut (Fukamachi and Takayama, 1980; Kedinger et al., 1986) , kidney (Saxen and Sariola, 1987; Saxen and Thesleff, 1992) , and teeth . Although much is known about the mechanisms underlying these inductive interactions, little is yet known about the nature and identity of the major signaling molecules involved in the reciprocal inductive processes. Based on its spatial and temporal expression pattern in early embryogenesis, we suggest that GDNF is one such factor regulating the epithelial-mesenchymal interactions in those organs and tissues in which it is expressed.
The development of the kidney depends on reciprocal epithelial-mesenchymal interactions.
The mature mammalian kidney, the metanephros, develops from three cell lineages, the ureter epithelium, the mesenchymal cells of the nephric blastema and the endothelial cells of the capillaries (Saxen and Sariola, 1987; Saxen and Thesleff, 1992) . Organogenesis of the kidney involves a cascade of inductive interactions among these tissues, the primary regulatory component being the ureter. Upon initial stimulation by the metanephrogenic mesenchyme, the branching ureter determines the time and site of appearance of the nephrons by inducing the mesenchymal cells to condense and differentiate around its tips into the epithelial elements of the secretory portions of the nephron, the glomeruli and proximal and distal tubules. This nephron forming tissue, in turn, induces further branching of the ureteric buds. The branched ureteric bud forms the renal collecting ducts, ureter, and a connection with the nephric tubules.
Differentiation of the mesenchymal cells into epithelial elements of the nephron involves major remodeling of the extracellular matrix (ECM) which is secreted by the uninduced mesenchyme (Gilbert, 1994) . It is thought that the signal mediating kidney mesenchyme induction is a secreted peptide associated with the ECM. One candidate is syndecan, a cell-surface-associated, heparin-sulfate-rich proteoglycan (Vainio et al., , 1992 . Syndecan expression is detected in the mesenchyme immediately following induction and its appearance precedes the disappearance of certain collagens and the enhanced synthesis of several matrix molecules in the ECM , suggesting that it regulates the condensation of the mesenchyme and promotes the proliferation of these cells. We have observed early GDNF expression in the uninduced mesenchyme, suggesting that GDNF may be the inductive signaling factor in the cortical mesenchyme that precedes syndecan expression. TGF,B also has a positive, proliferative effect on ECM formation; it increases production and decreases degradation of ECM proteins Ziyadeh, 1993, 1994; Border, 1994) .
Studies on the interaction of the gut epithelium and gut mesenchyme during development have shown that in the morphogenesis of the digestive tract, the endodermal epithelium gives rise to different structures when induced by different regionally specific mesenchymes (Fukamachi and Takayama, 1980; Mizuno and Yasugi, 1990) . Kedinger et al. (1986) demonstrated that culturing fetal endodermal cells with fetal gut mesenchyme induced the differentiation of the endodermal cells into villi and crypts and the four main small intestinal cell types. Further, they found that the mesenchyme was induced by the associated epithelial cells to differentiate into intestinal muscle layers and connective tissue. Thus, differentiation of the specialized regions of the gut is a result of the reciprocal interaction of the endodermal epithelium with the overlying, adjacent ectomesoderm.
The early and notably intense expression of GDNF in the mesodermal mesenthyme surrounding the gut endoderm and its continued expression in the outer smooth muscle layers of the gut throughout the entire length of the digestive tube suggests it plays an important role in the differentiation of the various regions of the gut.
Reciprocal interactions between epithelial and mesenchymal tissues are also important for tooth morphogenesis (Thesleff et al., 1989 (Thesleff et al., , 1990 . In the mouse embryo, tooth development starts around day 10 when the oral epithelium thickens and forms an epithelial bud around which neural crest-derived mesenchymal cells condense. This condensation is induced by the epithelium which has odontogenic potential. Later, the inductive capacity shifts to the dental mesenchyme which can induce tooth formation when cultured in combination with nonoral epithelium (Mina and Kollar, 1987) . The dental epithelium forms the enamel organ which secretes the enamel matrix. The induced mesenchymal cells differentiate into odontoblasts which form the dentin and pulp of each tooth. When rat and mouse epithelial and mesenchymal tissues were cultured in various combinations, the presumptive dental epithelium appeared to induce the expression of the cell surface proteoglycan syndecan and the extracellular matrix glycoprotein tenascin in the underlying mesenchyme. It has been postulated that in the differentiation of the dental mesenchymal cells, these molecules function to mediate cell-matrix interactions in the condensed mesenchyme by binding together the induced mesenchymal cells Vainio and Thesleff, 1992a,b) . TGF-Pl is expressed in the dental epithelium when the teeth are at bud stage (E13.0) (Vaahtokari et al., 1991) and subsequently in the condensed mesenchyme, suggesting that it induces its own expression in the dental mesenchymal cells. Its expression in the epithelium is thought to regulate cell proliferation and possibly regulate syndecan and/or tenascin expression in the underlying dental mesenchyme. Another member of the TGF-/? family, BMP-4, which is initially expressed in presumptive dental epithelium, was also found to induce its own expression in adjacent dental mesenchyme (Vainio et al., 1993) . Both of these peptide growth factors are thought to mediate epithelial-mesenchymal interactions in other tissues as well as during tooth development (Heine et al., 1987) . The results of our study showing the expression of GDNF in the tooth mesenchyme are consistent with a role in epithelial-mesenchymal interactions during tooth morphogenesis.
Interestingly, GDNF expression in the tail bud and lateral plate mesoderm is also very reminiscent of the expression pattern of BMP4. Recently, BMP-4 has been shown to play a role in the lateralization of the somite (Olivier Pourquie, personal communication).
The expression pattern of GDNF and its proposed functions are entirely consistent with the known functions of other TGF-/3 superfamily members which are expressed in differentiating tissues of mesenchymal origin and are implicated in inductive interactions between epithelia and mesenchyme (Heine et al., 1987; Schmid et al., 1991; Wall and Hogan, 1994) . Its neurotrophic activities are also consistent with those of other TGF-P family members (Poulsen et al., 1994; Kreiglstein et al., 1995) . The overlap of expression patterns of GDNF and other TGF-fi related genes indicates a functional complementation of the members of this large superfamily of genes.
Experimental Procedures
Cloning of the murine GDNF gene
Murine GDNF cDNA was amplified from adult mouse brain RNA by RT/PCR using primers derived from the rat cDNA clone (Lin et al., 1993) . Total mouse RNA was reverse transcribed with SuperScript RNase H-reverse transcriptase (RT) using random hexamer primers. To amplify GDNF, 2.5 ~1 of the RT reaction was added to a PCR reaction containing 50 pmol each of sense (S-CCGGAGACCGGATCCGAGGTG-3') and anti-sense (5'-CTCTGGAGCCAGGGTCAGAT-3') primers. The RT/PCR was performed according to established protocols (Davis et al., 1994) . The resulting PCR product was gel-purified, blunt-ended, kinased and subcloned into pGEM-4 vector. The subcloned fragment was sequenced on both strands by the dideoxy sequencing method using the Sequenase kit (Version 2, USB).
A 129/Sv mouse genomic library was made in the Lambda GEM-l 1 vector (Promega). One million recombinants were screened with the GDNF cDNA as a probe and positive clones were plaque purified and partially mapped. To confirm the sequence of the murine GDNF cDNA, Sac I fragments of the genomic clones containing the coding exons were subcloned and the exons were sequenced using the Taq DyeDeoxy Terminator Cycle Sequencing Kit and run on an Applied Biosystems 373A DNA Sequencer.
In situ hybridization of mouse embryos
GDNF mRNA was detected in whole mount embryos and in embryo sections by in situ hybridization using as a probe a 299 bp region of mGDNF from the second coding exon. The template DNA was amplified by PCR using primers that incorporated T3 and T7 recognition sites at the 5' and 3' ends. The primer with the T3 recognition site (5'-CGCGCAATTAACCCTCACTAAAGGGGGTGC G-TTITAACTGCCAT-3') and the primer with the T7 recognition site (5'-GCGCGTAAT ACGACTCACTATAG-GGTCTGGAGCCAGGGTCAGATA-3') flank a fragment that would allow T3 polymerase to make a sense and T7 polymerase an antisense riboprobe. The PCR was performed according to standard protocols (Davis et al., 1994) . 35S-labeled riboprobes were made with the MAXIscript in vitro transcription kit (Ambion).
All in situ hybridization experiments were simultaneously carried out with a sense and antisense probe. The sense probe gave no specific hybridization signal. However, using whole mount in situ hybridizations we often observed staining around the otic vesicle with both probes, which is due to an artifact.
Mouse embryos were fixed for 2 h in 4% paraformaldehyde and whole mount in situ hybridization was carried out as described earlier (Robinson and Mahon, 1994) with the Genius RNA labeling and detection kit (Boehringer Mannheim) using the PCR amplified GDNF DNA as template. Embryos were photographed on Kodak Ektachrome 160T film with a Zeiss photomicroscope III.
Gestational days ElO.S-E15.5 (day of plug was E0.5 days) were collected and frozen in OCT Compound (Miles, Elkhart, IN) on dry ice. Sections (12pm) of the embryos were cut in a cryostat, thaw-mounted onto silanized slides, air-dried and stored at -70°C until processed. The slides were processed for in situ hybridization as previously described (Bradley et al., 1992) . Briefly, the slides were fixed in 4% paraformaldehyde/PBS, treated with acetic anhydride to reduce background, dehydrated, delipidated in chloroform and incubated overnight at 55°C with the hybridization buffer containing either sense or antisense riboprobes. The next day, slides were washed at high stringency (0.1 X SSC/l mM D'lT at 65"C, final wash) to remove unbound probe, dehydrated, dried and exposed to Kodak XAR film for l-3 days. They were then coated with NTB3 nuclear track emulsion (Kodak, Rochester, NY) and exposed for 3-6 weeks at 4°C. The slides were developed and counterstained with Giemsa solution (Fluka, diluted 1:l with PBS), coverslipped, examined and photographed under brightfield and darkfield illumination.
